Nasopharyngeal carcinoma INPC) is a rare disease in most parts of the globe but particularly concentrates in Cnina ana Southeast Asia. In Bangladesh, we come across a significant number of cases of Cn*Jnooc HPCs. Childhood nasopharyngeal carcinoma almost always have the undrrfercntialad wiMt of ttie disease, which is associated with advanced regional spread and distant mtaatmm. Bo* genetic and environmental factors contribute to the development of nasopharyngn* carcnoaa. Because childhood NPC has close association with EBV infection, WHO type • •vsaog** arc «ry high incidence of advanced-stage disease, it should be treated : disease i pathogenes& children.
Introduction
Nasopharyngeal carc:r.:-=i V?; condition arising from :he 3B of the nasopharynx, a stma area behind the nasal cavin inaccessible site. When a ta the subjective signs are poor become evident only when • considerably. Early diagnosis z difficult.
Nasopharyngeal carcinoma is oae • malignant tumours in childhood -^sx from the epithelium. It is distica the adult form of the disease due association with Epstein-Barr ^i nfection, its undifferentiated histology and the high incidence of regionally advanced disease.
Childhood nasopharyngeal carcinoma has distinct epidemiological, histopathological, and dinical characteristics. In pediatric population, r^L^t nasopharyngeal malignancies are icaoiogically classified as Undifferentiated .
•.
• ~~-^nd lymphoepilhelial carcinoma. Clinical Presentation History Nasopharyngeal carcinoma rarely comes to medical attention before it has spread to regional lymph nodes. Enlargement and extension of the tumour in the nasopharynx may result in symptoms of nasal obstruction (eg. congestion, nasal discharge, bleeding), change in hearing (usually associated with blockage of the Eustachian tube, but direct extension into ear is possible), and cranial nerve palsies (usually associated with extension of the tumour into the base of the skull)." 1 '" 12 
Physical Findings
The most common physical finding is a neck mass, which is observed in 80% of patients. 13 Painless firm lymph node enlargement is present. Neck involvement is often bilateral; the most common nodes involved are the jugulodigastric and upper and middle jugular nodes in the anterior cervical chain.
Another common presenting sign is unilateral serous otitis as a result of Eustachian tube occlusion by the primary tumour. 8 Cranial nerve infiltration with resultant palsy may also be present.
The differential diagnosis of nasopharyngeal cancer includes other nasopharyngeal or sinusoidal masses ( eg. Lymphoma, including Hodgkin's disease and lethal midline reticulosis), Wegners eranulomatosis and mucocele.
Histopathology
The World Health Organization (WHO) has classified NPC into three subtypes: Type I is keratinizing squamous cell carcinoma; Type II is a nonkeratinizing epidermoid carcinoma; and Type III is undifferentiated carcinoma. The neoplastic element is epithelial , although in tumours of WHO type II & III, lymphoid, plasmoid and eosinophilic cell infiltration is common. Type I is characterized by Keratin production. In Type II there are groups or bundles of cells with fusiform and oval nucleus and scant cytoplasm; Type Ha shows pleomorphism, whereas in Type lib , lymphoid infiltration is prominent. In Type III, also referred to as lymphoepithelioma or Schminke tumour, undifferentiated round cells with prominent nucleoli are the major cell type. This subgroup is characterized by nonmalignant lymphoid penetration. Large nucleoli and eosinophilic cytoplasm are specific type Ilia, whereas small nucleoli and basophilic structure indicate type Hlb.
11 ' 13 The most common histopathological type in children is WHO Type III. 16 
Diagnosis
Clinical examination reveals cervical lymphadenopathy, a nasopharyngeal mass mostly on the lateral or roof, or cranial nerve palsies. Computed tomography (CT) and magnetic resonance imaging (MRI) should be used to assess the extent of local tumour growth and base of skull involvement. MRI is more sensitive than CT for detection of the primary tumour and the extent of regional spread including nodal metastasis and perineural extension; CT is better than MRI for identification of bone erosion. For a definitive diagnosis an endoscopic examination and a biopsy from primary tumour should be done.
Chest radiographs along with CT, bone scans, and liver ultrasonography are the main investigation procedures for evaluation of distant metastasis. An aspiration biopsy of Bone marrow should be done for patients with advanced disease and . for patients with base of With radiotherapy alone, 5 year survival has been reported as 20-60% in most paediatric series. ' Doses of 50-70 GY directed to the primary tumour are recommended for patients older than 10 years and a 5-10% reduction in this dosage is recommended for children younger than 10 years of age.
C. Chemotherapy
In most childhood cancers, including EBVrelated lymphoid malignant diseases, the use of radiotherapy is limited or substituted by systemic chemotherapy. The poor overall survival and high incidence of systemic failure in children with locally advanced NPC has led to the investigation of two different chemotherapy schedules; before(neoadjuvant) and after (adjuvant) radiotherapy .During the past 10 years, administration of adjuvant and neoadjuvant cisplantin based chemotherapy gained popularity. This approach is used with the aim of early eradication of microscopic disease and decrease in primary tumour mass before and after radiation. 13 15 Immanotherapy with anti-EBV T cells may be another promising approach in the treatment of EBV-related NPC. 26 
Conclusion
Childhood NPC is not a rare disease in this subcontinent It is rather common in Southeast Asia and we often encounter these cases in our routine medical practice. The variations in incidence of NPC between different geographical and ethnic groups indicates that both genetic and environmental factors contribute to its development. The uniqueness of the disease extends to iicameui policy and make NPC the only childhood disease in which radiotherapy is the primary treatment for locally and regionally confined stages. Also early administration of our effective chemotherapeutic agent is needed for treatment of Childhood NPC.
;:_"•; .:' .. gradually increased incidence of the disease in this territory nasopharyngeal cancer should be kept in mind when signs or symptoms of ear . nose and throat disease are present in our patients. 
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